Submit your email to push it up the queue
Martek Biosciences Corporation, a leading innovator in the biotechnology sector, is headquartered in the United States. Founded in 1985, the company has established itself as a key player in the development of nutritional products, particularly in the areas of omega-3 fatty acids and other essential nutrients. With a strong focus on health and wellness, Martek's core offerings include algal oils and DHA-rich products, which are renowned for their sustainability and health benefits. Over the years, Martek has achieved significant milestones, including partnerships with major food and beverage companies, solidifying its position in the global market. The company is recognised for its commitment to research and development, ensuring that its products meet the highest standards of quality and efficacy. As a pioneer in the industry, Martek Biosciences continues to lead the way in providing innovative solutions that support healthy living.
How does Martek Biosciences Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Martek Biosciences Corporation's score of 85 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Martek Biosciences Corporation, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of DSM-Firmenich AG, which influences its climate commitments and initiatives. While no absolute emissions figures are provided, Martek Biosciences Corporation is aligned with the sustainability goals set by its parent company, DSM-Firmenich AG. This includes participation in various climate initiatives such as the Science Based Targets initiative (SBTi) and the CDP (formerly Carbon Disclosure Project), which guide their emissions reduction strategies. As part of its commitment to sustainability, Martek is expected to adhere to the reduction targets and climate pledges established by DSM-Firmenich AG, although specific targets for Martek itself have not been disclosed. The company is also involved in initiatives like RE100 and the Race to Zero campaign, which further emphasise its dedication to reducing carbon emissions and promoting climate action. In summary, while specific emissions data for Martek Biosciences Corporation is not available, its climate commitments are shaped by its relationship with DSM-Firmenich AG, reflecting a broader corporate responsibility towards sustainability and emissions reduction.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|
Scope 1 | 1,030,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 590,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 8,683,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 00,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Martek Biosciences Corporation is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.